Here, we found that ZHX2 inhibited uptake of exogenous lipids in hepatocytes and suppressed NAFLD progression by transcriptionally repressing lipid lipase (LPL) expression. Here, ZHX2 is linked to metabolic dysfunction-associated steatotic liver disease.